Chem.
Pharm. Bull.
35 (10) 
Introduction
The rapid, single injection multiple indicator dilution (MID) method developed by Goresky et al. [1] [2] [3] ) is a very useful and elegant technique for the investigation of the uptake of materials from blood into the liver. It has provided an insight into the resistance to the influx and efflux processes at the cell membranes, in both the absence and presence of sequestration processes (intracellular metabolism, biliary excretion and/or intracellular transport). However, the parameters of the sequestration process obtained from the MID data in the case of low-clearance drugs, such as warfarin4) and tolbutamide,5) were usually much larger than those obtained from in vivo experiments,6,7) since this method is performed within such a short period (30 s) that neither metabolism nor biliary excretion can be entirely determined for such low-clearance drugs. Unfortunately, it is still not clear what sequestration process is being measured, but in the case of a high-clearance drug, the sequestration process observed by means of the MID method might be considered to reflect metabolism and/or excretion processes. The purpose of the present study was to determine whether the sequestration process obtained by using the MID method does reflect these processes in the case of a highclearance drug.
4-Methylumbelliferone (4-MU), which is used therapeutically as a cholagogue, is well known to be substantially cleared by conjugative metabolism in the liver. It has often been used as a model compound in conjugation studies.") In our previous study, we found a remarkable dose-dependency in the hepatic elimination of 4-MU.101 Moreover, utilizing the MID method, we found that the limiting step of the apparent hepatic intrinsic clearance of 4-MU changed with increasing dose owing to the saturation of the sequestration process.") Although we considered that the saturation of the sequestration process might be attributed to that of the conjugative metabolism, we have not demonstrated yet whether the metabolism of 4-MU actually occurs in such a short period (30 s). In the present study, using an in vivo tissue sampling single injection technique developed by Pardridge et al.,12-15) we examined whether conjugative metabolism occurred within such a short period. Furthermore, using the parameters obtained from the MID data, we simulated the time profiles of the amounts of drugs remaining in the liver, according to the "sinusoidal" mode1,161 which breaks up the sinusoid into a large number of sequentially perfused compartments with accompanying cellular compartments.
Experimental

Materials
4-MU, its glucuronide (4-MUG) and sulfate (4-MUS) and bovine serum albumin (BSA) (fraction V) were purchased from Sigma Chemical Co. (St. Louis, MO). Beta-Glucuronidase/arylsulfatase was purchased from Boehringer Mannheim GmbH (Mannheim, West Germany). All other reagents were commercial products of analytical grade.
In Vivo Tissue-Sampling Single Injection Technique The technique used in the present study was basically according to Pardridge et al.'2-'5) Male Wistar rats (weighing 250-300 g) maintained on a normal laboratory diet, were used throughout. Under light ether anesthesia, a midline abdominal incision was made and the hepatic artery was ligated. Immediately after ligation of the hepatic artery, the portal vein was canulated with a 25-gauge needle and 300 pl of the injection solution (low dose, 110 p/rat; high dose, 3200 pg/rat) was rapidly injected. The injection solution was made by mixing equal volumes of rat plasma and Krebs-Ringer buffer containing the test substance. At particular times (20, 40 and 60 s) after portal injection, the portal vein was rapidly cut off and the whole liver tissue was excised. Immediately after excision, the whole tissue was frozen in a bath of acetone cooled to -70 °C with dry ice and kept at -40 °C until assayed. The amounts of 4-MU taken up into the liver and its metabolites generated intracellularly were determined individually by using thin layer chromatography as described in detail previously.")
The fractions of the dose for 4-MU, 4-MUG and 4-MUS remaining in the liver after injection of 4-MU are designated as FDapp ,,_,u, FD app,4-MUG and FDapp,4-MUS, respectively. It is assumed that no biliary excretion of the parent drug (4-MU) or its metabolites (4-MUG and 4-MUS) occurs during such a short period. No metabolism other than sulfation and glucuronidation occurs in the body.") Since 4-MUG and 4-MUS formed from 4-MU may be effectively trapped in the liver due to their low diffusional clearances between the blood and hepatocytes,") FDapp ,4-MUG and FDapp,4_mus may reflect the extents of the conjugative metabolism of 4-MU. Therefore, the sum of FDapp ,4_muG and FDapp,4_mus. was designated as the extent of the conjugative metabolism of 4-MU (Eseq). In this method, the recirculation of 4-MU might slight even at 60 s, since more than 90% of the injected 4-MU was still taken up in the liver at 40 s and the steady-state distribution volume of 4-MU (290 ml/kg) was very large.") Furthermore, according to the "sinusoidal" mode1,16) we simulated the time profiles of the amounts of drugs remaining in the liver, using parameters obtained from the MID data. The "sinusoidal" model breaks up the sinusoid into a large number of sequentially perfused compartments with accompanying cellular compartments. The system used for simulation was a portal vein bolus injection. For the sake of simplicity, several assumptions were made, as follows; no biliary excretion is assumed for the parent drug (4-MU) and its metabolites (4-MUG and 4-MUS) during such a short period. The volumes of blood and the liver, and the intrinsic clearance for the influx, efflux and sequestration processes are identical with regard to all compartments.
In the case of the n-compartment sinusoidal model, in which the sinusoid is broken up into n sequentially perfused compartments with accompanying cellular compartments, the following mass-balance equations hold in the i-th compartment: for the extracellular space (1) and for the intracellular space (2) where Q is the hepatic blood flow; t is the time; CB, and CL, are the concentrations in the extracellular and intracellular spaces of the i-th compartment (i= 1 -,n), respectively; fB represents the unbound fraction in the blood (fB = 0.91; in vivo experiments")) or the perfusate (fB = 0.88; perfusion experiments11)); VE and VL are the volumes of the extracellular and intracellular spaces, respectively; CLI""tf CL,, and CL7neZnare the intrinsic clearances for the influx, efflux and sequestration processes in the n-compartment sinusoidal model, respectively. In the case of a portal vein injection, the above equations are integrated from t = 0 to oo. Subsequently, rearranging all equations, we obtained the dose-normalized A U Cn(area under the outflow fraction of dose (per ml) v.s. time) of the n-th compartment as follows:
where CL"represents the apparent intrinsic clearance in the n-compartment sinusoidal model. Since A U Cnis identical to the instantaneous hepatic availability (F), the instantaneous hepatic extraction ratio (E) is expressed as follows: (5) Rearranging Eq.5 to solve for CL ff,P ,yields: metabolites in the effluent perfusate within a short period ( < 30 s) by means of the MID method.") 4-MUG and 4-MUS were found to show low diffusional clearance between the blood and hepatocytes by using isolated hepatocytes. Consequently, the fractions of the amounts of 4-MUG and 4-MUS remaining in the liver (FDapp ,4-MUG, FDapp,4_mus, respectively) were considered to reflect the extents of the conjugative metabolism, on the ground that 4-MUG and 4-MUS formed from 4-MU were effectively trapped in the hepatocytes by the diffusional barrier between the blood and hepatocytes.17 Thus, it was suggested that saturation of the conjugative metabolism actually occurred for .a short period when the dose was increased, and the saturation of the sequestration process observed by means of the MID method might reflect that of the conjugative metabolism. The values of FDapp ,4-MUG at the low dose and FDapp ,4_mus at the low and high doses were almost constant irrespective of time, whereas the value of FDapp ,4_mu decreased with time at both doses. On the other hand, the values of FDapp ,4_muG at the high dose gradually increased with time, whereas the value of FDapp ,4_mu decreased. Simulation Study According to the "sinusoidal" model, we simulated FDapp ,4_mu and Eseq, using the parameters obtained from the MID data.") The relationships between FDapp,4_mu and Eseq (20 and 60 s after bolus portal vein injection) and the sinusoidal compartment number (N) are depicted in Figs. 1 and 2 . When the N value became more than 7, the values of F D app ,4_mu and Eseq were almost constant irrespective of the N value. Since the concentration gradient along the hepatic blood flow path in the "sinusoidal" model becomes sharper as the N value is increased, this model might be considered to be identical with the "parallel" tube model, in the range of larger N value (more than 7). The results of simulation with the model, in which the sinusoid has 20 sinusoidal compartments, at low and high doses are depicted in Fig. 3 . This model could predict the values of FDapp ,4_mu and Eseq well at both low and high doses. 
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Discussion
The MID method has been extensively used to clarify the physiology of various organs such as the heart,201 kidney,211 and liver.' 3) This method has the advantage that three parameters with regard to the influx, efflux and sequestration (metabolism, biliary excretion and/or intracellular transport) processes are determined simultaneously and individually. However, the experimental period is so short that we cannot easily determine what the sequestration process is.
We will consider the relationship between the intrinsic clearance for the sequestration process observed by means of the MID method and that in vivo. The hepatic clearance (CLH) is a function of the hepatic blood flow (QH), the blood unbound fraction (fB) and the apparent intrinsic clearance (CL MPH), and can be expressed according to the following two models22); namely, the "well-stirred" model, which describes the liver as a well-stirred compartment, and the "parallel tube" model, which describes the liver as a series of identical and parallel tubes with enzymes distributed evenly within hepatocytes lining the tubes. In these two models,CLH is expressed by the following equations.23) For the well-stirred model:
For the parallel tube model:
For either model, CLH is expressed by (9) Table I , the value of Eseq at the low dose (0.69) was much higher than that at the high dose (0.08) at 20 s. Thus, it was suggested that conjugative metabolism actually occurred during this short period and was saturated at the high dose. At the low dose, the value of Eseq was constant independent of time, whereas the value of FD app ,4-MU decreased with time (Table I ). In contrast, at the high dose, Eseq gradually increased, whereas the value of FDapp ,4-MU decreased as in the case of the low dose, although the absolute values of FDapp ,4-MU were different between the low and high doses ( Table I) . The difference in Eseq between the low and high doses might be explained as follows. At the low dose, 4-MU was removed to a large extent by the conjugativemetabolism. On the other hand, at the high dose, a large amount of 4-MU remained in the liver due to the saturation of the conjugative metabolism. At the high dose, the conjugative metabolism might continue for 60 s and therefore, the value of Eseq gradually increased with time. In contrast, the value of FDapp,4-MU decreased with time due to both wash-out with the hepatic blood flow and conjugative metabolism. 
